Abdelilah Aboussekhra
Riyadh, 11211, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Recombinant Human Decorin Normalizes the Active Features of Breast Cancer-Associated Fibroblasts.
Journal: Cells
Published: January 05, 2026
Eugenoplatin (a phyto-chemo drug conjugate) targets cancer stem cells through inhibition of the β-catenin signaling in triple-negative breast cancer cells.
Journal: Journal of translational medicine
Published: December 04, 2025
Safety and preliminary efficacy of adding tocilizumab to cisplatin/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1/2 clinical trial.
Journal: Scientific reports
Published: October 30, 2025
Obesity is a major modifiable factor associated with ER-negative breast cancer: epidemiological and mechanistic evidence from a high-risk cohort.
Journal: Breast cancer research : BCR
Published: September 15, 2025
A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort study.
Journal: Cell death discovery
Published: April 05, 2025
Molecular Subtypes of Breast Cancer in Arab Women: Distribution and Prognostic Insights.
Journal: Journal of epidemiology and global health
Published: January 14, 2025
Eugenol Promotes Apoptosis in Leukemia Cells via Targeting the Mitochondrial Biogenesis PPRC1 Gene.
Journal: Cells
Published: January 07, 2025
Identification of novel prognostic biomarkers for thyroid cancer by integrated transcriptome analysis of metastasis-associated genes.
Journal: Frontiers in oncology
Published: November 28, 2024
Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis.
Journal: Frontiers in endocrinology
Published: October 20, 2024
Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling.
Journal: Cells
Published: February 08, 2024
Last Updated: 09/26/2026